Abstract:
The COVID-19 is quickly spreading globally, and the number of cases in Europe and the United States is highly increasing. Compared to diseases caused by earlier identified human CoVs, COVID-19 displays higher transmission competence with minimal so ere pathogenesis. as is obvious from the unceasingly increasing numeral of confirmed cases. Older adults with diabetes, respiratory disease, cardiovascular disease, etc., are more likely to be infected with COVID-19, and COVID-19 disease affects older adults with underlying chronic conditions more than other age groups. Comorbidities are known to aggravate the course ofCOVID-19 and increase the risk of death associated with COVID-19. However, one factor that makes it difficult for older adults to fight infection is that they have a weaker immune system than other individuals. Another group that the new coronavirus, SARS-CoV-2 could infect is children. However, they seem to be lesser sensitive to infections than adults and COVID-19 symptoms are usually milder. There are currently no scientific data with a sufficient loci of evidence regarding the treatments for COVID-19 infection in children. Therefore, COVID-19 for children's treatment recommendations should be evaluated according to adult studies and pediatric patients. We highlight the diagnostic. clinical epidemiological, radiological characteristics laboratory and treatment in adults and children in the present study.
Description:
Bu yayın 06.11.1981 tarihli ve 17506 sayılı Resmî Gazete’de yayımlanan 2547 sayılı Yükseköğretim Kanunu’nun 4/c, 12/c, 42/c ve 42/d maddelerine dayalı 12/12/2019 tarih, 543 sayılı ve 05 numaralı Üniversite Senato Kararı ile hazırlanan Sakarya Üniversitesi Açık Bilim ve Açık Akademik Arşiv Yönergesi gereğince telif haklarına uygun olan nüsha açık akademik arşiv sistemine açık erişim olarak yüklenmiştir.
